Sort by
Keyphrases
Fatty Acid Amide Hydrolase
100%
Anandamide
36%
TRP Channels
36%
Capsaicin
36%
Genomic Deletion
27%
KO Mice
27%
Wild Mice
18%
Spinal Cord
18%
Paw Skin
18%
Clinical Trials
9%
Induced Activation
9%
Genotype
9%
Prostaglandin E2
9%
Arachidonic Acid
9%
Analgesic
9%
Endocannabinoids
9%
2-Arachidonoylglycerol (2-AG)
9%
Pharmacological Inhibitors
9%
Lack of Efficacy
9%
Spinal Dorsal Horn
9%
Lumbar Spinal Cord
9%
Neuronal Activation
9%
Lipidome
9%
Cannabinoid Receptor 1 (CB1R)
9%
Pain Types
9%
Antinociception
9%
Intradermal Injection
9%
AMG9810
9%
Endogenous Lipids
9%
Central Sensitization
9%
Lipid Signaling Molecules
9%
Fatty Acid Amide Hydrolase Inhibitors
9%
Mechanical Hypersensitivity
9%
Human Pain Model
9%
AM251
9%
Immunoreactive Cells
9%
Nociceptive Response
9%
V1a Receptor
9%
Nociceptive Processing
9%
Carrageenan Model
9%
Heat Hypersensitivity
9%
Nocifensive Behavior
9%
Biologically Active Lipids
9%
Fatty Acid Amides
9%
Inflammatory Nociception
9%
Tail-flick Test
9%
Formalin Model
9%
Medicine and Dentistry
Fatty Acid Amidase
100%
Capsaicin
36%
Anandamide
36%
Vanilloid Receptor 1
36%
Gene Deletion
27%
Knockout Mouse
27%
Paw Skin
18%
Clinical Trial
9%
Immunocompetent Cell
9%
Signaling Molecule
9%
Tail
9%
Fatty Acid
9%
Hypersensitivity
9%
Nociception
9%
Arachidonic Acid
9%
Carboxamide
9%
Sensitization
9%
Horn
9%
Antinociception
9%
Prostaglandin E2
9%
N (1,4 Benzodioxan 6 Yl) 3 (4 Tert Butylphenyl)acrylamide
9%
Carrageenan
9%
Endocannabinoid
9%
Lumbar Spinal Cord
9%
Cannabinoid Receptor
9%
Intradermal Drug Administration
9%
Lipidome
9%
Fatty Acid Amidase Inhibitor
9%
Vasopressin V1 Receptor
9%
1 (2,4 Dichlorophenyl) 5 (4 Iodophenyl) 4 Methyl N (1 Piperidyl) 1h Pyrazole 3 Carboxamide
9%
Pharmacology, Toxicology and Pharmaceutical Science
Fatty Acid Amidase
100%
Anandamide
36%
Capsaicin
36%
Vanilloid Receptor 1
36%
Knockout Mouse
27%
Wild Type Mouse
18%
Clinical Trial
9%
Fatty Acid
9%
Arachidonic Acid
9%
Analgesic Agent
9%
Carboxamide
9%
Endocannabinoid
9%
Prostaglandin E2
9%
Carrageenan
9%
Erethism
9%
Antinociception
9%
Fatty Acid Amidase Inhibitor
9%
Cannabinoid Receptor
9%
Lipidome
9%
N (1,4 Benzodioxan 6 Yl) 3 (4 Tert Butylphenyl)acrylamide
9%
Vasopressin V1 Receptor
9%
AM251
9%
Neuroscience
Fatty Acid Amidase
100%
Vanilloid Receptor 1
33%
Capsaicin
33%
Anandamide
33%
Gene Deletion
25%
Agonist
16%
Behavior (Neuroscience)
8%
Arachidonic Acid
8%
Nociception
8%
Prostaglandin E2
8%
Cannabinoid Receptor
8%
Hydrolase Inhibitor
8%
Endocannabinoid
8%
Lipid Signaling
8%
AM251
8%
Lipidome
8%
Carrageenan
8%
Vasopressin V1 Receptor
8%
Fatty Acid Amides
8%